Hormonveränderungen bei Intensivpatienten

Schlüsselwörter

Intensivmedizin - Niedrig-T3-Syndrom - Nebennierenrindeninsuffizienz - CIRCI - Hyperglykämie - Wachstumshormondefizienz

Keywords

critical care medicine - non thyroidal illness syndrome - adrenal insufficiency - CIRCI - hyperglycemia - growth hormone deficiency

• Literatur

• 1 American Diabetes A. Standards of medical care in diabetes – 2013. Diabetes Care 2013; 36 (Suppl. 01) S11-66
• 2 Annane D, Maxime V, Ibrahim F et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174: 1319-1326
• 3 Bello G, Ceaichisciuc I, Silva S et al. The role of thyroid dysfunction in the critically ill: a review of the literature. Minerva Anestesiol 2010; 76: 919-928
• 4 De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 2006; 22: 57-86, vi
• 5 Deane AM, Horowitz M. Dysglycaemia in the critically ill – significance and management. Diabetes Obes Metab 2013; 15: 792-801
• 6 Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
• 7 Gibson SC, Hartman DA, Schenck JM. The endocrine response to critical illness: update and implications for emergency medicine. Emerg Med Clin North Am 2005; 23: 909-929, xi
• 8 Marik PE, Pastores SM, Annane D et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937-1949
• 9 Moghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-1131
• 10 Müller TD, Tschöp MH. Ghrelin – a key pleiotropic hormone-regulating systemic energy metabolism. Endocr Dev 2013; 25: 91-100
• 11 Ranasinghe AM, Bonser RS. Endocrine changes in brain death and transplantation. Best Pract Res Clin Endocrinol Metab 2011; 25: 799-812
• 12 Saberi F, Heyland D, Lam M et al. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr 2008; 32: 227-235
• 13 Takala J, Ruokonen E, Webster NR et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792
• 14 Tognini S, Marchini F, Dardano A et al. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age Ageing 2010; 39: 46-50
• 15 Van den Berghe G. Endocrine evaluation of patients with critical illness. Endocrinol Metab Clin North Am 2003; 32: 385-410
• 16 Van den Berghe G, Wilmer A, Milants I et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55: 3151-3159
• 17 Vanhorebeek I, Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr Opin Pharmacol 2004; 4: 621-628